Sample result
GLP-1, a diabetes hormone
A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.
The search
- Query
- GLP-1 · 31 lettersHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG
- Search
- Protein → Patent proteins · Automatic (Smith-Waterman)
- Set
- Public patent sequences: Patent proteins, snapshot 2026-11-05-c456f6bdba29
- Ran
- 2026-11-12
- Found
- 5,000 sequences, 3,061 publications, 1,851 families
Smith-Waterman compares each query with every stored sequence. Each query returns up to 5,000 sequences, with the best alignment of each. FASTA36 fits its E-values to a random sample of scores, so a sequence near the cutoff can come and go between runs. These results do not establish patentability.
Patents
3,061 publications in 1,851 families match these filters.
-
JP 2025161829-A2025-10-24
Patent application sequence for JP 2025161829-A/10
GAN & LEE PHARMACEUTICALS CO., LTD
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
EP 4637820-A12025-10-29
METHODS OF REDUCING CONTAMINANTS IN PROTEIN PURIFICATION
LILLY CO ELI
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
EP 4637947-A12025-10-29
METHODS OF CLEANING CHROMATOGRAPHY MATRICES
LILLY CO ELI
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
EP 4637955-A12025-10-29
METHODS OF REDUCING CONTAMINANTS IN PROTEIN PURIFICATION
LILLY CO ELI
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
WO 2025227129-A22025-10-30
DELIVERY VEHICLES COMPRISING PROGLUCAGON DERIVED POLYPEPTIDES AND ANABOLIC POLYPEPTIDES AND USES THEREOF
STARROCK PHARMA LLC
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 7 to 37. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 7 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3731 of 31 identical, no gaps.
-
EP 4642475-A22025-11-05
ARTIFICIAL SECRETION PEPTIDES FOR HETEROLOGOUS PROTEIN PRODUCTION
TENZA INC
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
WO 2025230947-A12025-11-06
ENGINEERED HEPATOCYTES FOR SECRETING POLYPEPTIDES
SATELLITE BIOSCIENCES INC
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
KR 1020250162632-A2025-11-18
INHIBITORS OF EXPRESSION AND/OR FUNCTION
TANGRAM THERAPEUTICS PLC
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
EP 4652190-A12025-11-26
LIQUID PHARMACEUTICAL COMPOSITIONS OF FUSION POLYPEPTIDES AND METHODS OF USES THEREOF
BEIJING QL BIOPHARMACEUTICAL CO LTD
Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- EP 4652190-A12025-11-26
- JP 2026504873-A2026-02-10
-
WO 2025242620-A12025-11-27
POLYPEPTIDE COMBINATIONS AND USES THEREOF
MEDIMMUNE LTD
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
WO 2025245160-A12025-11-27
MYOSTATIN-SELECTIVE INHIBITORS FOR TREATING METABOLIC DISORDERS
SCHOLAR ROCK INC
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
KR 1020250167609-A2025-12-01
FUSION COMPOUNDS AND USES THEREOF
NOVO NORDISK A/S
Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020250167609-A2025-12-01
- JP 2026518098-A2026-06-04
-
KR 1020250169638-A2025-12-03
COMPOUNDS OF DRUGS WITH AN ALBUMIN BINDING MOIETY
Ascendis Pharma A/S
Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020250169638-A2025-12-03
- JP 2026509252-A2026-03-17
-
WO 2025248124-A12025-12-04
DAPIGLUTIDE FOR USE IN TREATING A SUB-GROUP OF SUBJECTS
ZEALAND PHARMA AS
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2025179167-A2025-12-09
Patent application sequence for JP 2025179167-A/1
CYPRUMED GMBH
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
US 12497438-B22025-12-16
Compounds
IP2IPO Innovations Limited
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
WO 2025257294-A12025-12-18
SOLUBLE GLP1/GIP/NPY2 RECEPTOR TRIPLE AGONISTS
BOEHRINGER INGELHEIM INT GMBH
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
EP 4667498-A12025-12-24
GLP-1 ANALOG-FC FUSION PROTEIN AND USE THEREOF
ZHANG JING
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2025542352-A2025-12-25
GLP1/GIP/NPY2 RECEPTOR TRIPLE AGONISTS
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
WO 2026013135-A12026-01-15
ALBUMIN-BINDING REAGENTS
ASCENDIS PHARMA AS
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
WO 2026013136-A12026-01-15
ALBUMIN-BINDING COMPOUNDS
ASCENDIS PHARMA AS
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
WO 2026013138-A12026-01-15
COMPOUNDS WITH IMPROVED ALBUMIN-BINDING
ASCENDIS PHARMA AS
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
WO 2026017381-A12026-01-22
OPTIMIZED BACILLUS HOST CELLS
NOVOZYMES AS
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2026016423-A2026-02-03
DOSING REGIMEN OF GLP-1
SHANGHAI BENEMAE PHARMACEUTICAL CORPORATION
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
US 12539326-B22026-02-03
Methods for treating Alzheimer's disease using semaglutide
Novo Nordisk A/S
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
EP 4686757-A12026-02-04
INHIBITORS OF EXPRESSION AND/OR FUNCTION
E THERAPEUTICS PLC
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
WO 2026030354-A22026-02-05
OPTIMIZED DNA CASSETTES FOR GENE THERAPY
REMEDIUM BIO INC
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2026021305-A2026-02-10
Patent application sequence for JP 2026021305-A/10
SUPITTOFAIA FAMA ERUERUSI
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
EP 4691496-A12026-02-11
PHARMACEUTICAL PREPARATION CONTAINING GLP-1 FUSION PROTEIN AND USE THEREOF
GUANGZHOU INNOGEN PHARMACEUTICAL GROUP CO LTD
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2026505829-A2026-02-18
INHIBITORS OF EXPRESSION AND/OR FUNCTION
E-THERAPEUTICS PLC
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2026507086-A2026-02-27
Novel fusion protein and use thereof
SL BIGEN, Inc
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2026507088-A2026-02-27
COMPOUNDS
IP2IPO INNOVATIONS LIMITED
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
EP 4719498-A12026-04-08
RADIOLIGANDS FOR TARGETING CELL SURFACE RECEPTORS AND USES THEREOF
FULL LIFE TECH UK LIMITED
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
EP 4727963-A22026-04-22
GENE THERAPIES FOR METABOLIC DISORDERS
FRACTYL HEALTH INC
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
EP 4733314-A12026-04-29
NOVEL BISPECIFIC FUSION PROTEIN AND USE THEREOF
SLBIGEN INC
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2026075626-A2026-05-08
NOVEL GLP-1 ANALOGUES
Sun Pharmaceutical Industries Ltd
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
US 12636250-B22026-05-26
Microneedle array patches (MAPs), systems, and methods for manufacturing and using same
Terrestrial Bio, Inc.
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
EP 4750795-A12026-06-03
STABILIZED GLP-1 PEPTIDES AND DUAL AGONIST PEPTIDES AGAINST GLP-1R AND GIPR AND METHODS OF USE THEREOF
BIOMEDIT INC
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2026519911-A2026-06-19
Patent application sequence for JP 2026519911-A/10
Guangzhou Innogen Pharmaceutical Group Co., Ltd.
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
WO 2026143180-A12026-07-02
ANTI-CB1 ANTIBODY COMPOSITIONS AND THERAPEUTIC CONJUGATES THEREOF
SKYE BIOSCIENCE INC
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
WO 2026152012-A12026-07-16
GLP1R AGONIST-TETHERED GDF8 ANTIBODY CONJUGATES AND USES THEREOF
REGENERON PHARMA
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
EP 4777544-A12026-07-22
CD98HC ANTIBODY AND USE THEREOF
4B TECH SUZHOU LIMITED
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
EP 4792828-A12026-08-19
GLP -1 PEPTIDE COMPOSITION AND USE THEREOF
GAN & LEE PHARMACEUTICALS CO LTD
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
EP 4803076-A12026-09-09
TRANSMUCOSAL THERAPEUTIC SYSTEM CONTAINING A GLP-1 RECEPTOR AGONIST
LTS LOHMANN THERAPIE SYSTEME AG
Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
Family of 2
Grouped by a shared priority claim, EP20250161437.
- EP 4803076-A12026-09-09
- WO 2026185181-A12026-09-10
-
EP 4803077-A12026-09-09
COMPOSITION FOR OROMUCOSAL ADMINISTRATION COMPRISING PERMEATION ENHANCERS
LTS LOHMANN THERAPIE SYSTEME AG
Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
Family of 2
Grouped by a shared priority claim, EP20250161438.
- EP 4803077-A12026-09-09
- WO 2026185182-A12026-09-10
-
EP 4803106-A22026-09-09
GLP-1 RECEPTOR LIGAND MOIETY CONJUGATED OLIGONUCLEOTIDES AND USES THEREOF
ASTRAZENECA AB
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
EP 4806456-A12026-09-16
GLP-1 COMPOUND FOR LOWERING SUGAR LEVELS
GAN & LEE PHARMACEUTICALS CO LTD
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
EP 4806457-A12026-09-16
GLP-1 COMPOUND FOR WEIGHT LOSS
GAN & LEE PHARMACEUTICALS CO LTD
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
WO 2026209522-A12026-10-08
ALK7 COMBINATION TREATMENTS
NOVO NORDISK AS
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
WO 2026209706-A12026-10-08
NOVEL AFFINITY LIGANDS FOR THE PURIFICATION OF GLUCAGON-LIKE PEPTIDE (GLP-1) RECEPTOR AGONISTS
NAVIGO PROTEINS GMBH
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.